Concepedia

Olav Dajani

OD

24

Publications

1.3K

Citations

18

H-Index

1990

Active since

Affiliations

University of Oslo(Current)

Oslo University Hospital

OsloMet – Oslo Metropolitan University

University of South-Eastern Norway

UiT The Arctic University of Norway

Olav Dajani is an author at University of Oslo specializing in medicine, liver physiology, and health sciences.

ORCID

Top concepts

Publications per year

1990–2025

24

Publications

24

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Kjell Magne Tveit, Tormod Kyrre Guren, Bengt Glimelius et al. · Journal of Clinical Oncology · 2012 · 527 citations

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

Julian Hamfjord, Tormod Kyrre Guren, Olav Dajani et al. · Annals of Oncology · 2019 · 74 citations · Full text

, , +7

Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours

Sarina A. Piha‐Paul, P.N. Munster, Antoine Hollebecque et al. · European Journal of Cancer · 2015 · 73 citations

, , +8

Stimulatory and inhibitory effects of catecholamines on DNA synthesis in primary rat hepatocyte cultures: Role of alpha<sub>1</sub>‐ and beta‐adrenergic mechanisms

Magne Refsnes, G. Hege Thoresen, Dagny Sandnes et al. · Journal of Cellular Physiology · 1992 · 57 citations

Stimulation of hepatocyte DNA synthesis by prostaglandin E<sub>2</sub> and prostaglandin F<sub>2</sub>α additivity with the effect of norepinephrine, and synergism with epidermal growth factor

Magne Refsnes, G. Hege Thoresen, Olav Dajani et al. · Journal of Cellular Physiology · 1994 · 57 citations

Rows per page

1–5 of 24